TickerFacts.

Company research / OCGN

Ocugen, Inc. (OCGN)

Build a valuation ↗↓ Download CSV

CIK 0001372299 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Ocugen, Inc. reported revenue of $4.41M. Revenue grew 8.8% from the prior annual period.

Key ratios (year ended 2025-12-31)

-1425.7%
Operating margin
-1537.4%
Net margin
8.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-06

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
Revenue$4.41M$4.05M$6.04M———$2.49M———
Operating Income-$62.92M-$54.76M-$65.53M———-$89.07M———
Net Income-$67.85M-$54.05M-$63.08M———-$86.80M———
EPS (Diluted)——$-0.26———$-0.40———
Total Assets$43.52M$82.44M$64.55M$74.69M$88.98M$96.30M$108.63M$116.24M$130.09M$141.73M
Total Liabilities$55.68M$52.81M$23.98M$24.89M$29.73M$31.40M$34.65M$30.55M$23.61M$16.21M
Shareholders' Equity-$12.17M$29.63M$40.56M$49.80M$59.24M$64.90M$73.98M$85.69M$106.48M$125.52M
Cash & Equivalents——$39.46M$53.48M$70.58M$68.26M$77.56M$101.60M$115.00M$129.77M
Operating Cash Flow-$56.96M-$42.14M-$62.05M———-$60.08M———
Capital Expenditures$185.0K$3.38M$10.48M———$4.46M———
Shares Outstanding312.38M291.37M256.57M———221.60M———
Weighted Average Diluted Shares——244.33M———214.60M———
EPS (Basic)——$-0.26———$-0.40———